Wellington Management Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-518,146
| Closed | -$43.3M | – | 1934 |
|
|
2020
Q3 | $43.3M | Sell |
518,146
-298,249
| -37% | -$24.9M | 0.01% | 737 |
|
|
2020
Q2 | $60M | Buy |
816,395
+107,443
| +15% | +$7.9M | 0.01% | 649 |
|
|
2020
Q1 | $30.1M | Buy |
708,952
+9,616
| +1% | +$408K | 0.01% | 767 |
|
|
2019
Q4 | $42.6M | Sell |
699,336
-280,556
| -29% | -$17.1M | 0.01% | 806 |
|
|
2019
Q3 | $40.2M | Sell |
979,892
-297,197
| -23% | -$12.2M | 0.01% | 778 |
|
|
2019
Q2 | $60.2M | Sell |
1,277,089
-177,541
| -12% | -$8.36M | 0.01% | 705 |
|
|
2019
Q1 | $52M | Buy |
1,454,630
+613,192
| +73% | +$21.9M | 0.01% | 721 |
|
|
2018
Q4 | $24M | Buy |
841,438
+68,965
| +9% | +$1.97M | 0.01% | 934 |
|
|
2018
Q3 | $34.3M | Sell |
772,473
-238,942
| -24% | -$10.6M | 0.01% | 921 |
|
|
2018
Q2 | $59.4M | Buy |
1,011,415
+91,901
| +10% | +$5.4M | 0.01% | 733 |
|
|
2018
Q1 | $42M | Buy |
+919,514
| New | +$42M | 0.01% | 838 |
|
|
2017
Q2 | – | Sell |
-747,450
| Closed | -$16.3M | – | 2175 |
|
|
2017
Q1 | $16.3M | Buy |
747,450
+3,070
| +0.4% | +$66.8K | ﹤0.01% | 1096 |
|
|
2016
Q4 | $15M | Buy |
+744,380
| New | +$15M | ﹤0.01% | 1082 |
|